Global Famciclovir API Market Growth 2024-2030

Publication ID:

LPI01241426

Publication Date:

January 11, 2024

Pages:

123

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Famciclovir API market size was valued at US$ 13 million in 2023. With growing demand in downstream market, the Famciclovir API is forecast to a readjusted size of US$ 15 million by 2030 with a CAGR of 2.4% during review period.
The research report highlights the growth potential of the global Famciclovir API market. Famciclovir API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Famciclovir API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Famciclovir API market.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Key Features:
The report on Famciclovir API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Famciclovir API market. It may include historical data, market segmentation by Type (e.g., Insourced, Outsourced), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Famciclovir API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Famciclovir API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Famciclovir API industry. This include advancements in Famciclovir API technology, Famciclovir API new entrants, Famciclovir API new investment, and other innovations that are shaping the future of Famciclovir API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Famciclovir API market. It includes factors influencing customer ' purchasing decisions, preferences for Famciclovir API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Famciclovir API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Famciclovir API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Famciclovir API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Famciclovir API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Famciclovir API market.
Market Segmentation:
Famciclovir API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Insourced
Outsourced
Others
Segmentation by application
Tablet Product
Capsule Product
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Key Questions Addressed in this Report
What is the 10-year outlook for the global Famciclovir API market?
What factors are driving Famciclovir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famciclovir API market opportunities vary by end market size?
How does Famciclovir API break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Famciclovir API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Famciclovir API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Famciclovir API by Country/Region, 2019, 2023 & 2030
2.2 Famciclovir API Segment by Type
2.2.1 Insourced
2.2.2 Outsourced
2.2.3 Others
2.3 Famciclovir API Sales by Type
2.3.1 Global Famciclovir API Sales Market Share by Type (2019-2024)
2.3.2 Global Famciclovir API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Famciclovir API Sale Price by Type (2019-2024)
2.4 Famciclovir API Segment by Application
2.4.1 Tablet Product
2.4.2 Capsule Product
2.4.3 Others
2.5 Famciclovir API Sales by Application
2.5.1 Global Famciclovir API Sale Market Share by Application (2019-2024)
2.5.2 Global Famciclovir API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Famciclovir API Sale Price by Application (2019-2024)
3 Global Famciclovir API by Company
3.1 Global Famciclovir API Breakdown Data by Company
3.1.1 Global Famciclovir API Annual Sales by Company (2019-2024)
3.1.2 Global Famciclovir API Sales Market Share by Company (2019-2024)
3.2 Global Famciclovir API Annual Revenue by Company (2019-2024)
3.2.1 Global Famciclovir API Revenue by Company (2019-2024)
3.2.2 Global Famciclovir API Revenue Market Share by Company (2019-2024)
3.3 Global Famciclovir API Sale Price by Company
3.4 Key Manufacturers Famciclovir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famciclovir API Product Location Distribution
3.4.2 Players Famciclovir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Famciclovir API by Geographic Region
4.1 World Historic Famciclovir API Market Size by Geographic Region (2019-2024)
4.1.1 Global Famciclovir API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Famciclovir API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Famciclovir API Market Size by Country/Region (2019-2024)
4.2.1 Global Famciclovir API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Famciclovir API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Famciclovir API Sales Growth
4.4 APAC Famciclovir API Sales Growth
4.5 Europe Famciclovir API Sales Growth
4.6 Middle East & Africa Famciclovir API Sales Growth
5 Americas
5.1 Americas Famciclovir API Sales by Country
5.1.1 Americas Famciclovir API Sales by Country (2019-2024)
5.1.2 Americas Famciclovir API Revenue by Country (2019-2024)
5.2 Americas Famciclovir API Sales by Type
5.3 Americas Famciclovir API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famciclovir API Sales by Region
6.1.1 APAC Famciclovir API Sales by Region (2019-2024)
6.1.2 APAC Famciclovir API Revenue by Region (2019-2024)
6.2 APAC Famciclovir API Sales by Type
6.3 APAC Famciclovir API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Famciclovir API by Country
7.1.1 Europe Famciclovir API Sales by Country (2019-2024)
7.1.2 Europe Famciclovir API Revenue by Country (2019-2024)
7.2 Europe Famciclovir API Sales by Type
7.3 Europe Famciclovir API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Famciclovir API by Country
8.1.1 Middle East & Africa Famciclovir API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Famciclovir API Revenue by Country (2019-2024)
8.2 Middle East & Africa Famciclovir API Sales by Type
8.3 Middle East & Africa Famciclovir API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famciclovir API
10.3 Manufacturing Process Analysis of Famciclovir API
10.4 Industry Chain Structure of Famciclovir API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famciclovir API Distributors
11.3 Famciclovir API Customer
12 World Forecast Review for Famciclovir API by Geographic Region
12.1 Global Famciclovir API Market Size Forecast by Region
12.1.1 Global Famciclovir API Forecast by Region (2025-2030)
12.1.2 Global Famciclovir API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Famciclovir API Forecast by Type
12.7 Global Famciclovir API Forecast by Application
13 Key Players Analysis
13.1 Chongqing Shenghuaxi Pharma
13.1.1 Chongqing Shenghuaxi Pharma Company Information
13.1.2 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolios and Specifications
13.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chongqing Shenghuaxi Pharma Main Business Overview
13.1.5 Chongqing Shenghuaxi Pharma Latest Developments
13.2 Aurobindo Pharma Limited
13.2.1 Aurobindo Pharma Limited Company Information
13.2.2 Aurobindo Pharma Limited Famciclovir API Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Aurobindo Pharma Limited Main Business Overview
13.2.5 Aurobindo Pharma Limited Latest Developments
13.3 Apotex Pharmachem
13.3.1 Apotex Pharmachem Company Information
13.3.2 Apotex Pharmachem Famciclovir API Product Portfolios and Specifications
13.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Apotex Pharmachem Main Business Overview
13.3.5 Apotex Pharmachem Latest Developments
13.4 Changzhou Kony Pharma Co
13.4.1 Changzhou Kony Pharma Co Company Information
13.4.2 Changzhou Kony Pharma Co Famciclovir API Product Portfolios and Specifications
13.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Changzhou Kony Pharma Co Main Business Overview
13.4.5 Changzhou Kony Pharma Co Latest Developments
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Information
13.5.2 Teva Pharmaceutical Industries Famciclovir API Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Teva Pharmaceutical Industries Main Business Overview
13.5.5 Teva Pharmaceutical Industries Latest Developments
13.6 Olon
13.6.1 Olon Company Information
13.6.2 Olon Famciclovir API Product Portfolios and Specifications
13.6.3 Olon Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Olon Main Business Overview
13.6.5 Olon Latest Developments
13.7 Fuan Pharmaceutical
13.7.1 Fuan Pharmaceutical Company Information
13.7.2 Fuan Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.7.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fuan Pharmaceutical Main Business Overview
13.7.5 Fuan Pharmaceutical Latest Developments
13.8 Zhejiang Charioteer Pharmaceutical
13.8.1 Zhejiang Charioteer Pharmaceutical Company Information
13.8.2 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhejiang Charioteer Pharmaceutical Main Business Overview
13.8.5 Zhejiang Charioteer Pharmaceutical Latest Developments
13.9 Jialin Pharmaceutical
13.9.1 Jialin Pharmaceutical Company Information
13.9.2 Jialin Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jialin Pharmaceutical Main Business Overview
13.9.5 Jialin Pharmaceutical Latest Developments
13.10 Zhejiang Hisun
13.10.1 Zhejiang Hisun Company Information
13.10.2 Zhejiang Hisun Famciclovir API Product Portfolios and Specifications
13.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Zhejiang Hisun Main Business Overview
13.10.5 Zhejiang Hisun Latest Developments
13.11 Hetero
13.11.1 Hetero Company Information
13.11.2 Hetero Famciclovir API Product Portfolios and Specifications
13.11.3 Hetero Famciclovir API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hetero Main Business Overview
13.11.5 Hetero Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂